Answers are grounded in this paper and cite their sources.
Myocardial regeneration through regulatory protein expression or exogenous cardiomyocyte grafting represents a potential future therapeutic approach for end-stage heart disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Soonpaa et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: